Maryland, 28 Nov 2022: The FDA is investigating the risk of severe hypocalcemia in patients on dialysis treated with the osteoporosis drug Prolia, according to a drug safety communication.

 

The agency said hospitalizations and death have been reported among ......
View Details

Related News

• Medicine sales by dealers to retailers stood at Rs 1.40 lakh cr in Apr-Dec: Mandaviya (08-02-2023)

---

• Huge quantity of fake cosmetics seized in Ranchi (08-02-2023)

---

• NIPER-Ahmedabad conducts training on sophisticated analytical instruments (08-02-2023)

---

• Hair relaxers cause cancer and other health problems, 57 Lawsuits (08-02-2023)

---

• Dehradun police seize over 600 fake degrees of 5 states' universities, Ukraine varsity (08-02-2023)

---

• Methotrexate linked to increased risk of three types of skin cancer (08-02-2023)

---

• Private Blood bank raided running without licence in Gudivada (08-02-2023)

---

• AP gang illegally supplying Chloral Hydrate via maharshtra in Gujarat (07-02-2023)

---

• Stocking drugs without licence: Man gets 3-yr jail (07-02-2023)

---

• Unsafe levels of lead in 57% of 147 blood samples: AG Diagnostics (07-02-2023)

---